Latest Breaking News On - விக் நியூஃபெல்ட் - Page 1 : comparemela.com
Going Public: Psychedelics Execs Talk Opportunities and Challenges
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Every time Irwin Simon buys a new company or brand, his barber gets upset.
âIâm very superstitious,â said Simon, chief executive officer of Tilray Inc. âDuring a deal, I never get a haircut.â
Depending on how the next few years go, the 63-year-old executive might have a hard time staying well-coiffed if deal activity in the fast-paced cannabis sector continues to heat up. Simon â who in previous roles sold everything from diet drinks to free-range organic chicken - now has one goal ahead of him: running the biggest pot company in the world.
And as he looks forward to capturing a bigger slice of the global cannabis pie, his business acumen, developed over decades in various marketing and management roles, will be put to the test as rivals in the U.S. are already generating oodles of cash in a market where the more established Canadian players remain on the outside looking in.
The Companies Tackling A Global Health Crisis
FN Media Group Presents Financialmorningpost.com Market Commentary
News provided by
Share this article
Share this article
NEW YORK, May 20, 2021 /PRNewswire/ The global market for psychedelic drug treatments and therapy is in the early stages of what looks to be a massive shift. A growing wave of research has shown the power of psychedelics in offering effective treatments for mental health disorders such as depression, anxiety, and more. Mentioned in today s commentary includes:
Pfizer, Inc. (NYSE: PFE),
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA),
Johnson & Johnson (NYSE: JNJ),
Merck & Co., Inc (NYSE: MRK),
For years, some smart investors have been making money from the healthcare sector. Cutting-edge healthcare technologies and trends such as CRISPR, RNA, AI, and Cannabis all provided smart investors with major opportunities. Over the last decade, the biotech sector has been making profits and minting some millionaires, with the sector’s best-known benchmark
SPDR Biotech ETF(XBI) even
outgunning the red-hot tech sector’s
Technology Select Sector SPDR ETF(XLK) with a 460% vs. 420% return. But now the global pandemic has created a surge in demand for products addressing immunity and cognitive support. We think the next big trend in 2021 is a new class of therapeutics focused on the big 3 mental disorders…
vimarsana © 2020. All Rights Reserved.